Nevro Historical Balance Sheet

NVRO Stock

USD 4.58 0.26 6.02%

Trend analysis of Nevro Corp balance sheet accounts such as Total Stockholder Equity of 255.5 M provides information on Nevro Corp's total assets, liabilities, and equity, which is the actual value of Nevro Corp to its prevalent stockholders. By breaking down trends over time using Nevro Corp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Nevro Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nevro Corp is a good buy for the upcoming year.

Nevro Corp Inventory

78.75 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

About Nevro Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Nevro Corp at a specified time, usually calculated after every quarter, six months, or one year. Nevro Corp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nevro Corp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nevro currently owns. An asset can also be divided into two categories, current and non-current.

Nevro Corp Balance Sheet Chart

At this time, Nevro Corp's Net Invested Capital is very stable compared to the past year. As of the 28th of November 2024, Net Working Capital is likely to grow to about 473 M, while Total Assets are likely to drop about 461.8 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Net Receivables

Add Fundamental

Total Assets

Total assets refers to the total amount of Nevro Corp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nevro Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Nevro Corp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nevro Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Nevro Corp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nevro Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.At this time, Nevro Corp's Net Invested Capital is very stable compared to the past year. As of the 28th of November 2024, Net Working Capital is likely to grow to about 473 M, while Total Assets are likely to drop about 461.8 M.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	44.5M	45.3M	53.7M	34.2M
Total Assets	574.5M	602.4M	635.7M	461.8M

Other Current Liab Total Assets

Nevro Corp balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock
Total Assets		0.91	0.86	0.97	0.42	0.87	0.86	-0.86	0.89	0.68	0.63	0.6	0.61	0.97	0.93	0.92	0.94	0.91	0.91	0.91	0.87	0.96	0.98	0.7	1.0	0.92
Other Current Liab	0.91		0.67	0.83	0.42	0.9	0.77	-0.86	0.84	0.7	0.69	0.81	0.52	0.79	0.98	0.87	0.92	0.71	0.97	0.95	0.93	0.93	0.94	0.74	0.89	0.86
Total Current Liabilities	0.86	0.67		0.81	0.29	0.71	0.9	-0.64	0.64	0.38	0.44	0.41	0.84	0.92	0.7	0.64	0.68	0.93	0.63	0.61	0.66	0.75	0.86	0.52	0.87	0.65
Total Stockholder Equity	0.97	0.83	0.81		0.41	0.79	0.76	-0.8	0.91	0.71	0.56	0.51	0.56	0.97	0.86	0.95	0.93	0.91	0.83	0.88	0.78	0.93	0.91	0.63	0.98	0.95
Other Liab	0.42	0.42	0.29	0.41		0.57	0.38	-0.52	0.59	0.03	0.28	0.21	0.15	0.4	0.39	0.38	0.42	0.45	0.42	0.38	0.13	0.51	0.41	0.36	0.41	0.39
Property Plant And Equipment Net	0.87	0.9	0.71	0.79	0.57		0.73	-0.91	0.81	0.66	0.69	0.67	0.53	0.79	0.85	0.77	0.82	0.72	0.88	0.79	0.85	0.93	0.89	0.78	0.84	0.76
Net Debt	0.86	0.77	0.9	0.76	0.38	0.73		-0.66	0.61	0.26	0.47	0.52	0.77	0.87	0.81	0.64	0.69	0.91	0.77	0.68	0.71	0.75	0.9	0.54	0.86	0.64
Retained Earnings	-0.86	-0.86	-0.64	-0.8	-0.52	-0.91	-0.66		-0.82	-0.7	-0.89	-0.54	-0.29	-0.77	-0.82	-0.79	-0.82	-0.69	-0.88	-0.81	-0.81	-0.92	-0.86	-0.94	-0.83	-0.78
Accounts Payable	0.89	0.84	0.64	0.91	0.59	0.81	0.61	-0.82		0.72	0.55	0.54	0.4	0.83	0.85	0.88	0.95	0.75	0.82	0.9	0.72	0.93	0.83	0.62	0.89	0.89
Cash	0.68	0.7	0.38	0.71	0.03	0.66	0.26	-0.7	0.72		0.59	0.49	0.15	0.57	0.67	0.77	0.78	0.39	0.7	0.77	0.8	0.77	0.63	0.62	0.66	0.75
Non Current Assets Total	0.63	0.69	0.44	0.56	0.28	0.69	0.47	-0.89	0.55	0.59		0.51	0.08	0.52	0.62	0.59	0.6	0.43	0.71	0.64	0.69	0.69	0.67	0.99	0.58	0.57
Non Currrent Assets Other	0.6	0.81	0.41	0.51	0.21	0.67	0.52	-0.54	0.54	0.49	0.51		0.54	0.46	0.78	0.64	0.68	0.39	0.7	0.71	0.75	0.6	0.65	0.51	0.58	0.64
Other Assets	0.61	0.52	0.84	0.56	0.15	0.53	0.77	-0.29	0.4	0.15	0.08	0.54		0.68	0.56	0.44	0.48	0.73	0.4	0.39	0.5	0.47	0.63	0.15	0.64	0.46
Cash And Short Term Investments	0.97	0.79	0.92	0.97	0.4	0.79	0.87	-0.77	0.83	0.57	0.52	0.46	0.68		0.82	0.86	0.86	0.98	0.79	0.79	0.75	0.89	0.93	0.6	0.98	0.87
Net Receivables	0.93	0.98	0.7	0.86	0.39	0.85	0.81	-0.82	0.85	0.67	0.62	0.78	0.56	0.82		0.86	0.94	0.76	0.96	0.95	0.92	0.92	0.94	0.68	0.92	0.86
Common Stock Total Equity	0.92	0.87	0.64	0.95	0.38	0.77	0.64	-0.79	0.88	0.77	0.59	0.64	0.44	0.86	0.86		0.94	0.77	0.87	0.91	0.81	0.9	0.86	0.64	0.91	1.0
Common Stock Shares Outstanding	0.94	0.92	0.68	0.93	0.42	0.82	0.69	-0.82	0.95	0.78	0.6	0.68	0.48	0.86	0.94	0.94		0.76	0.91	0.98	0.86	0.95	0.9	0.66	0.93	0.94
Short Term Investments	0.91	0.71	0.93	0.91	0.45	0.72	0.91	-0.69	0.75	0.39	0.43	0.39	0.73	0.98	0.76	0.77	0.76		0.71	0.7	0.64	0.8	0.88	0.51	0.93	0.78
Non Current Liabilities Total	0.91	0.97	0.63	0.83	0.42	0.88	0.77	-0.88	0.82	0.7	0.71	0.7	0.4	0.79	0.96	0.87	0.91	0.71		0.95	0.92	0.94	0.94	0.76	0.89	0.85
Inventory	0.91	0.95	0.61	0.88	0.38	0.79	0.68	-0.81	0.9	0.77	0.64	0.71	0.39	0.79	0.95	0.91	0.98	0.7	0.95		0.88	0.93	0.9	0.68	0.9	0.9
Other Current Assets	0.87	0.93	0.66	0.78	0.13	0.85	0.71	-0.81	0.72	0.8	0.69	0.75	0.5	0.75	0.92	0.81	0.86	0.64	0.92	0.88		0.87	0.9	0.73	0.84	0.8
Other Stockholder Equity	0.96	0.93	0.75	0.93	0.51	0.93	0.75	-0.92	0.93	0.77	0.69	0.6	0.47	0.89	0.92	0.9	0.95	0.8	0.94	0.93	0.87		0.95	0.77	0.94	0.89
Total Liab	0.98	0.94	0.86	0.91	0.41	0.89	0.9	-0.86	0.83	0.63	0.67	0.65	0.63	0.93	0.94	0.86	0.9	0.88	0.94	0.9	0.9	0.95		0.73	0.97	0.85
Property Plant And Equipment Gross	0.7	0.74	0.52	0.63	0.36	0.78	0.54	-0.94	0.62	0.62	0.99	0.51	0.15	0.6	0.68	0.64	0.66	0.51	0.76	0.68	0.73	0.77	0.73		0.66	0.62
Total Current Assets	1.0	0.89	0.87	0.98	0.41	0.84	0.86	-0.83	0.89	0.66	0.58	0.58	0.64	0.98	0.92	0.91	0.93	0.93	0.89	0.9	0.84	0.94	0.97	0.66		0.91
Common Stock	0.92	0.86	0.65	0.95	0.39	0.76	0.64	-0.78	0.89	0.75	0.57	0.64	0.46	0.87	0.86	1.0	0.94	0.78	0.85	0.9	0.8	0.89	0.85	0.62	0.91

Click cells to compare fundamentals

Nevro Corp Account Relationship Matchups

Nevro Corp balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	469.6M	789.4M	574.5M	602.4M	635.7M	461.8M
Other Current Liab	54.6M	42.2M	44.5M	45.3M	53.7M	34.2M
Total Current Liabilities	70.6M	239.2M	82.2M	79.2M	83.4M	71.3M
Total Stockholder Equity	216.4M	388.5M	303.6M	323.9M	293.1M	255.5M
Other Liab	1.9M	3.3M	22.0M	2.2M	2.5M	3.6M
Property Plant And Equipment Net	33.3M	31.7M	38.2M	35.7M	33.5M	19.1M
Net Debt	115.4M	282.6M	132.0M	76.8M	117.6M	85.6M
Retained Earnings	(409.8M)	(492.8M)	(624.2M)	(607.2M)	(699.4M)	(664.4M)
Accounts Payable	16.0M	23.1M	32.0M	26.8M	22.5M	19.3M
Cash	65.4M	44.6M	34.7M	120.4M	104.2M	58.2M
Non Current Assets Total	47.6M	36.3M	43.3M	39.5M	104.8M	110.0M
Non Currrent Assets Other	13.3M	4.0M	4.5M	3.2M	5.8M	4.5M
Other Assets	14.3M	22.8M	5.1M	3.8M	1.0	0.95
Cash And Short Term Investments	237.8M	588.0M	362.0M	374.4M	322.7M	289.0M
Net Receivables	82.8M	77.7M	70.5M	78.9M	79.4M	57.9M
Common Stock Shares Outstanding	30.8M	33.7M	34.8M	35.5M	36.0M	26.7M
Short Term Investments	172.4M	543.4M	327.3M	254.0M	218.5M	230.8M
Liabilities And Stockholders Equity	469.6M	789.4M	574.5M	602.4M	635.7M	461.8M
Non Current Liabilities Total	182.7M	161.8M	188.7M	199.3M	259.2M	135.1M
Inventory	91.6M	83.3M	93.5M	99.6M	118.7M	78.7M
Other Current Assets	9.8M	8.3M	5.2M	10.0M	10.1M	6.7M
Other Stockholder Equity	626.4M	880.7M	928.1M	934.1M	992.8M	588.4M
Total Liab	253.3M	401.0M	270.9M	278.5M	342.6M	206.3M
Property Plant And Equipment Gross	33.3M	31.7M	38.2M	35.7M	69.2M	72.6M
Total Current Assets	422.1M	753.1M	531.2M	562.9M	530.9M	432.0M
Accumulated Other Comprehensive Income	(313K)	598K	(364K)	(3.1M)	(243K)	(255.2K)
Property Plant Equipment	11.8M	13.5M	20.7M	22.3M	25.6M	26.9M
Short Long Term Debt Total	180.7M	327.2M	166.7M	197.2M	221.8M	172.5M
Net Tangible Assets	216.4M	388.5M	303.6M	323.9M	372.5M	291.2M
Long Term Debt	160.3M	141.8M	151.3M	186.9M	211.5M	145.9M
Retained Earnings Total Equity	(409.8M)	(492.8M)	(624.2M)	(607.2M)	(546.5M)	(573.8M)
Long Term Debt Total	160.3M	141.8M	151.3M	186.9M	214.9M	136.3M
Capital Surpluse	626.4M	880.7M	928.1M	934.1M	1.1B	686.8M
Non Current Liabilities Other	22.4M	20.0M	37.4M	12.5M	43.1M	45.2M
Net Invested Capital	376.7M	699.0M	454.9M	510.7M	504.6M	524.5M
Net Working Capital	351.4M	513.9M	449.0M	483.7M	447.5M	473.0M

Pair Trading with Nevro Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against Nevro Stock

0.61	LNSR	LENSAR Inc	Pair Corr
0.58	CAH	Cardinal Health	Pair Corr
0.48	VMD	Viemed Healthcare	Pair Corr
0.48	WGS	GeneDx Holdings Corp	Pair Corr
0.45	VREX	Varex Imaging Corp	Pair Corr

The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.

The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:

How To Invest In Nevro

Details

Is Nevro Stock a good investment?

Details

What is Nevro Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.87)

Revenue Per Share

11.404

Quarterly Revenue Growth

(0.07)

Return On Assets

(0.09)

Return On Equity

(0.25)

The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nevro Historical Balance Sheet

Nevro Corp Inventory

78.75 Million

About Nevro Balance Sheet Analysis

Nevro Corp Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Nevro Corp balance sheet Correlations

Nevro Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nevro Corp balance sheet Accounts

Pair Trading with Nevro Corp

Moving against Nevro Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Common Stock	+ 1.0	Common Stock Total Equity
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets
Net Receivables	+ 0.98	Other Current Liab
Total Current Assets	+ 0.98	Total Stockholder Equity

Property Plant And Equipment Gross	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.92	Retained Earnings
Retained Earnings	- 0.91	Property Plant And Equipment Net
Non Current Assets Total	- 0.89	Retained Earnings
Non Current Liabilities Total	- 0.88	Retained Earnings
Total Liab	- 0.86	Retained Earnings